Interaction Between Genes and Environment in Inherited Lipid Disorders Determines Clinical Presentation

Lipoprotein and lipid metabolism disorders. In: The Metabolic Basis of Inherited Disease, 7th edn., Scriver CR Beaudet AL, Sly WS, and Valle D, eds., NewYork: McGraw-Hill, 1995: Part 8, Ch. 57-65, 1841–2099. Ginsberg HN, Goldberg IJ. Disorders of lipoprotein metabolism. In: Harrison's Principles of Internal Medicine, 14th edn., Fauci AS, Braunwald E, Iselbacher KJ, et al., eds., New York: McGraw-Hill, 1998:2138–2149. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336–45. Jansen ACM, van Wissen S, Defesche JC, Kastelein JJP. Phenotypic variability in familial hypercholesterolemia: An update. Curr Opin Lipidol 2002;13:165–171. Sijbrands EJG, Westendorp RGJ, Defesche JC, de Meier PHEM, Smelt AHM, Kastelein JJP. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: Familee tree mortality study. BMJ 2001;322:1019–1023. Evans V, Kastelein JJP. Lipoprotein lipase deficiency-Rare or common? Cardiovasc Drugs Ther 2003. Ose L. Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther 2003. Ordovas JM. HDL genetics: Candidate genes, genome wide scans and gene-environment interactions. Cardiovasc Drugs Ther 2003.